IMAX vs TECH · P/E 59, rev $352.2M vs P/E 65, rev $1.22B
Imax Corp (IMAX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Imax Corp (IMAX) is a entertainment company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IMAX revenue for 2024-12-31 was $352.2M. Net income was $32.7M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. IMAX currently screens at market cap $1.45B and trailing P/E 58.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IMAX currently screens at market cap $1.45B and trailing P/E 58.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IMAX and TECH stock pages for the full models.
Not investment advice.